Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in coccidioides posadasii

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2167-2170

  Brilhante, Raimunda Sâmia Nogueira ^a   De Lima, Rita Amanda Chaves ^a   Caetano, Erica Pacheco ^a   Leite, João Jaime Giffoni ^a   De Souza Collares Maia Castelo Branco, Débora ^a   Ribeiro, Joyce Fonteles ^a   De Jesus Pinheiro Gomes Bandeira, Tereza ^a   De Aguiar Cordeiro, Rossana ^a,c   Monteiro, André Jalles ^a   Sidrim, José Júlio Costa ^a,b   Rocha, Marcos Fábio Gadelha ^a,b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

^c Christus University Center   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOSTEROL; FARNESOL;

ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CELL MEMBRANE PERMEABILITY; COCCIDIOIDES; COCCIDIOIDES POSADASII; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; FUNGAL CELL; FUNGUS GROWTH; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; STEROL SYNTHESIS;

ANTIFUNGAL AGENTS; CELL MEMBRANE PERMEABILITY; COCCIDIOIDES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ERGOSTEROL; FARNESOL; FLUCONAZOLE; MICROBIAL SENSITIVITY TESTS; OSMOLAR CONCENTRATION; OSMOTIC PRESSURE; SODIUM CHLORIDE;

EID: 84876210061     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02457-12     Document Type: Article

References (29)

1. Fisher MC, Koenig GL, White TJ, Taylor JW. 2002. Molecular and phenotypic description Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis. Mycologia 94:73-84.
2. Parish JM, Blair JE. 2008. Coccidioidomycosis. Mayo Clin. Proc. 83:343-348.
3. Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Johnson RH, Stevens DA, Williams PL. 2005. Coccidioidomycosis. Clin. Infect. Dis. 41:1217-1223.
4. Johnson RH, Einstein HE. 2007. Amphotericin B and coccidioidomycosis. Ann. N. Y. Acad. Sci. 1111:434-441.
5. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R, Dussault P, Nickerson KW. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol. 67:2982-2992.
6. Cho T, Aoyama T, Toyoda M, Nakayama H, Chibana H, Kaminishi H, Calderone RA. 2008. Farnesol as a quorum-sensing molecule in Candida albicans. Nippon Ishinkin Gakkai Zasshi 49:281-286. (In Japanese.)
7. Ramage G, Saville SP, Wickes BL, López-Ribot JL. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463.
8. Jabra-Rizk MA, Shirtliff M, James C, Meiller T. 2006. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res. 6:1063-1073.
9. Deveau A, Piispanen AE, Jackson AA, Hogan DA. 2010. Farnesol induces hydrogen peroxide resistance in Candida albicans yeast by inhibiting the Ras-cAMP signaling pathway. Eukaryot. Cell 9:569-577.
10. Langford ML, Hasim S, Nickerson KW, Atkin AL. 2010. Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. Antimicrob. Agents Chemother. 54:940-942.
11. Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Harris SD. 2006. Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol. Microbiol. 59:753-764.
12. Inoue Y, Shiraishi A, Hada T, Hirose K, Hamashima H, Shimada J. 2004. The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol. Lett. 237:325-331.
13. Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. 2006. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob. Agents Chemother. 50:1463-1469.
14. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH. 2002. Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob. Agents Chemother. 46:1302-1309.
15. Semighini CP, Murray N, Harris SD. 2008. Inhibition of Fusarium graminearum growth and development by farnesol. FEMS Microbiol. Lett. 279:259-264.
16. Derengowski LS, De-Souza-Silva C, Braz SV, Mello-De-Sousa TM, Báo SN, Kyaw CM, Silva-Pereira I. 2009. Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann. Clin. Microbiol. Antimicrob. 8:13. doi:10.1186/1476-0711-8- 13.
17. Cordeiro RA, Nogueira GC, Brilhante RSN, Teixeira CEC, Mourão CI, Castelo-Branco DSCM, Araujo Neto PM, Ribeiro JF, Monteiro AJ, Sidrim JJC, Rocha MFG. 2012. Farnesol inhibits in vitro growth of the Cryptococcus neoformans species complex with no significant changes in virulence-related exoenzymes. Vet. Microbiol. 159:375-380.
18. Cordeiro RA, Teixeira CE, Brilhante RS, Castelo-Branco DS, Paiva MA, Giffoni Leite JJ, Lima DT, Monteiro AJ, Sidrim JJ, Rocha MF. 2013. Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. Med. Mycol. 51: 53-59.
19. Brilhante RS, Cordeiro RA, Rocha MF, Fechine MA, Furtado FM, Nagao-Dias AT, Camargo ZP, Sidrim JJ. 2008. Coccidioidal pericarditis: a rapid presumptive diagnosis by an in-house antigen confirmed by mycological and molecular methods. J. Med. Microbiol. 57:1288-1292.
20. Umeyama T, Sano A, Kamei K, Niimi M, Nishimura K, Uehara Y. 2006. Novel approach to designing primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification. J. Clin. Microbiol. 44:1859-1862.
21. Cordeiro RA, Brilhante RSN, Rocha MFG, Fechine MAB, Costa AK, Camargo ZP, Sidrim JJC. 2006. In vitro activities of caspofungin, amphotericin B and azoles against Coccidioides posadasii strains from northeast Brazil. Mycopathologia 161:21-26.
22. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi-2nd ed: approved standard M38-A2. CLSI, Wayne, PA.
23. Cordeiro RA, Brilhante RSN, Rocha MFG, Medrano JDA, Monteiro AJ, Tavares JL, Lima RAC, Camargo ZP, Sidrim JJC. 2009. In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii. Int. J. Antimicrob. Agents 34:278-280.
24. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. 2004. Combination antifungal therapy. Antimicrob. Agents Chemother. 48:693-715.
25. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. 1999. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 37:3332-3337.
26. Coleman JJ, Okoli I, Tegos GP, Holson EB, Wagner FF, Hamblin MR, Mylonakis E. 2010. Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem. Biol. 5:321-332.
27. Brilhante RS, Valente LG, Rocha MF, Bandeira TJ, Cordeiro RA, Lima RA, Leite JJ, Ribeiro JF, Pereira JF, Castelo-Branco DS, Monteiro AJ, Sidrim JJ. 2012. Sesquiterpene farnesol contributes to increased susceptibility to βlactams in strains of Burkholderia pseudomallei. Antimicrob. Agents Chemother. 56:2198-2200.
28. Brehm-Stecher BF, Johnson EA. 2003. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob. Agents Chemother. 47:3357-3360.
29. Navarathna DH, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW. 2007. Effect of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout mutant of Candida albicans. Infect. Immun. 75:1609-1618.